[HTML][HTML] New anticoagulants emerge, how can we use them for acute pulmonary embolism?

J Eckardt, M Nybo - Journal of Thoracic Disease, 2012 - ncbi.nlm.nih.gov
A patient with acute pulmonary embolism (PE) is a challenge to the clinician because most
treatments increase the risk for bleeding complications. Eighty percent of patients with PE …

New anticoagulants emerge, how can we use them for acute pulmonary embolism?

J Eckardt, M Nybo - Journal of Thoracic Disease, 2012 - jtd.amegroups.org
A patient with acute pulmonary embolism (PE) is a challenge to the clinician because most
treatments increase the risk for bleeding complications. Eighty percent of patients with PE …

[PDF][PDF] RESEARCH HIGHLIGHT

J Eckardt, M Nybo - Journal of Thoracic Disease, 2012 - cdn.amegroups.cn
A patient with acute pulmonary embolism (PE) is a challenge to the clinician because most
treatments increase the risk for bleeding complications. Eighty percent of patients with PE …

[引用][C] New anticoagulants emerge, how can we use them for acute pulmonary embolism?

J Eckardt, M Nybo - The Journal of Thoracic Disease, 2012 - portal.findresearcher.sdu.dk
New anticoagulants emerge, how can we use them for acute pulmonary embolism? —
University of Southern Denmark Skip to main navigation Skip to search Skip to main content …

[引用][C] New anticoagulants emerge, how can we use them for acute pulmonary embolism?

J Eckardt, M Nybo - Journal of thoracic disease, 2012 - pubmed.ncbi.nlm.nih.gov

New anticoagulants emerge, how can we use them for acute pulmonary embolism?

J Eckardt, M Nybo - Journal of Thoracic Disease, 2012 - europepmc.org
A patient with acute pulmonary embolism (PE) is a challenge to the clinician because most
treatments increase the risk for bleeding complications. Eighty percent of patients with PE …

New anticoagulants emerge, how can we use them for acute pulmonary embolism?

J Eckardt, M Nybo - Journal of Thoracic Disease, 2012 - europepmc.org
A patient with acute pulmonary embolism (PE) is a challenge to the clinician because most
treatments increase the risk for bleeding complications. Eighty percent of patients with PE …